Immune Modulation at the Maternal-Fetal Interface Research has demonstrated that hCG modulates immune responses at the maternal-fetal interface through epigenetic mechanisms specifically, hCG inhibits CXCL10 expression in human endometrial stromal cells by enhancing EZH2 expression and inducing H3K27me3 histone methylation at the CXCL10 promoter, thereby suppressing T cell recruitment to the implantation site
The panel begins its first session at approximately 10:15 a.m
Add methylmalonic acid if your result comes back borderline
Once your levels have been built back up, youll likely transition to maintenance mode with shots every month or so
Monitoring is important, especially for people with metabolic concerns, cancer history, or endocrine disorders
People respond to medication differently, so there is no set time for when you can expect to see results